In light of the poorly understood role of IGF2BP3 in modulating tumor cell functions, it is surprising to observe that there was an ‘explosion’ of descriptive studies published from 2007 onwards, which suggest IGF2BP3 expression to correlate with tumor aggressiveness in a broad variety of malignancies (Table 3). Here, IGF2BP3 is linked to neoplasm.